Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-21 Disposition | 2021-07-23 4:29 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 146,511 | $0 | 0 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:48 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 60,144 | $0 | 146,511 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-09 4:53 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 1,957 | $177 | 86,367 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-02 5:50 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 24,473 | $0 | 88,324 (Direct) | View |
| 2020-12-16 Tax Withholding | 2020-12-18 5:06 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 21,395 | $157.96 | 63,851 (Direct) | View |
| 2020-12-15 Option Award | 2020-12-18 5:06 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 40 | $93.53 | 63,851 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 5:06 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 40,677 | $0 | 63,851 (Direct) | View |
| 2020-06-08 Tax Withholding | 2020-06-09 4:59 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 2,784 | $114.61 | 44,529 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-03 6:26 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 1,396 | $90.54 | 47,313 (Direct) | View |
| 2019-12-15 Option Award | 2020-03-03 6:26 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 38 | $93.86 | 47,313 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 6:26 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 10,880 | $0 | 47,313 (Direct) | View |
| 2019-06-07 Tax Withholding | 2019-06-11 6:39 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 2,786 | $118.61 | 37,791 (Direct) | View |